Illustrative image.
A proposed SPAC merger would value Palm Beach Gardens-based Ampera at about $900 million before new investment. But the company’s nuclear technology remains in the regulatory-engagement stage, and Ampera is targeting October 2027 to submit a manufacturing and fuel fabrication license application to the U.S. Nuclear Regulatory Commission.
That timing is the central tension in the deal announced Tuesday. Ampera is seeking a public-market valuation now, while its nuclear product still has major development and licensing steps ahead.
The proposed merger with publicly traded Berto Acquisition Corp. could bring in up to $357 million in gross proceeds, assuming Berto shareholders do not redeem their shares. That figure is a maximum, not a guaranteed funding amount. If the transaction is completed, the combined company would trade on Nasdaq under the ticker AMPR. The companies are targeting a close in the first quarter of 2027.
The transaction remains proposed; it has not closed. Its headline valuation and potential proceeds should be read alongside the conditions that still stand between announcement and a public listing.
What is being valued today
Ampera’s strategy is called “Power Now, Nuclear Next.” The near-term step is to develop compact systems that generate electricity using conventional fuels or recovered industrial heat. The longer-term ambition is to introduce factory-built microreactors, subject to regulatory approval.
That sequencing matters. Ampera is targeting initial commercial deliveries in 2027 for a natural-gas-powered system designed to generate 7.5 megawatts of electricity. That is a separate proposition from the nuclear technology at the heart of the company’s longer-range plans.
The distinction is not a technicality. Based on the milestones Ampera has announced, the near-term power system is the closer-to-market part of the strategy. The nuclear business is a bet on what the company may be able to build and sell after further engineering work and regulatory review.
The company has not announced that its nuclear reactor is approved or licensed. Nor does a target date for submitting a license application mean the NRC will approve the technology, or decide on any particular timetable.

Illustrative image.
A licensing milestone, not a license
In October, Ampera submitted an early-site-permit-style regulatory engagement plan to the NRC. The company is targeting October 2027 to submit a manufacturing and fuel fabrication license application.
That places the planned application roughly 11 months after the proposed merger announcement. It does not mean the company expects to have a license in hand by then. Submitting an application is a step in a review process, not the outcome of that process.
The timing is important to investors assessing the distance between Ampera’s current position and its nuclear ambitions. For now, the application date is a company target. The regulatory engagement plan is an early stage of interaction with the commission, not approval of a reactor design or permission to manufacture fuel.
The company has also been building out technical partnerships. In August, Ampera announced work with Lawrence Livermore National Laboratory, part of the U.S. Department of Energy’s national laboratory system, focused on manufacturing methods for advanced thorium-based nuclear fuel.
In October, it announced a multiyear partnership with Imperial College London valued at approximately $9 million. The project, called NeuralTwin, combines artificial intelligence with physics-based computer models to help engineers design, test and improve complex energy systems.
Those efforts indicate areas of research and development; they do not remove the gap between present progress and regulatory approval. The same is true of Ampera’s July unveiling of a full-scale, 3D-printed nuclear reactor module. The company describes the spherical, monolithic gyroid core as made with silicon carbide and designed for up to 30 years of operation without refueling. That is a design aim, not a record of licensed commercial operation.

Illustrative image.
Why the company is pursuing “Power Now”
The appeal of Ampera’s pitch is tied to a pressing challenge for energy-intensive industries: where to secure enough electricity, and how soon it can be delivered. The expansion of AI infrastructure has sharpened attention on power supply, but a nuclear product with a long regulatory path cannot meet every near-term demand.
Ampera’s two-part strategy is built around that timing mismatch. Conventional-fuel and recovered-heat systems are intended to address nearer-term power needs, while the microreactor program represents a longer-term opportunity if the technology clears the required development and licensing hurdles.
“They want power now,” Ampera COO Robert Frost told Refresh Miami. “They don’t want it four years from now.”
That comment helps explain why the company is not presenting its nuclear technology as the only answer to immediate demand. But it also makes a clear-eyed reading of the proposed valuation more important: the company’s current story joins a near-term conventional-power product with a nuclear platform still working toward an application.
The announcements also show a company working on several fronts at once, but none of them changes the status of the nuclear license process.
The deal’s key caveats
The approximately $900 million valuation is before new investment. The “up to $357 million” figure depends on Berto shareholders not redeeming their shares and is stated as gross proceeds, not a guaranteed sum available at closing.
That caveat is material in a SPAC transaction. If shareholders redeem, the amount of cash available from the trust could be reduced. The proposed merger could also fail to close. For now, Nasdaq trading under AMPR and a first-quarter 2027 closing remain planned outcomes, not completed events.
Ampera founder and CEO Brian Matthews called the transaction “a defining milestone for AMPERA as we work to bring our advanced energy technologies to market.” It is a significant corporate step if completed. It is not a substitute for demonstrating that the products can be manufactured, deployed and, where nuclear technology is involved, licensed.
The company’s recent announcements show several workstreams moving at once: a proposed public listing, a conventional-fuel power system, research into advanced fuel, simulation tools, and regulatory engagement. Each is relevant. None should be mistaken for the others.

Illustrative image.
The gap behind the headline
The proposed SPAC deal puts a $900 million figure on Ampera before its targeted nuclear manufacturing and fuel fabrication license application is due. That application is still about 11 months away, and any review and approval would come later, if granted.
For readers following South Florida’s technology sector, the most useful way to understand the announcement is to keep the milestones separate. Ampera is seeking to take a near-term power system toward initial commercial deliveries while developing a much more ambitious nuclear business. The natural-gas 7.5-megawatt unit and the promise of a future reactor are both part of the company’s pitch, but they are at different stages.
The merger could give Ampera access to public markets and capital to advance its plans. It could also collapse, and the maximum proceeds are not assured. Either way, the license application target is the key marker to watch: it is a planned filing date, not proof that a commercial nuclear product is ready.
Sources: Refresh Miami’s report on the proposed merger; Ampera and Berto’s transaction announcement; Ampera’s NRC engagement plan announcement.

